If abiraterone becomes the standard care, will there be cost implications?

Christopher J. Logothetis, MD of MD Anderson Cancer Center discusses the impact of cost with the introduction of abiraterone as standard of care for patients with prostate cancer. This was recorded at... Author: obr Added: 06/21/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts